DOI : 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

Issue 12 · Volume 68 · December 2008 DOI: 10.1055/s-002-14837

Conference on Molecular Basics And Therapeutic Implications in Breast Cancer
1. COMBATing Breast Cancer Conference
Frankfurt, 21.–22. November 2008

Scientific Chairs: Prof. Dr. M. Kaufmann – Prof. Dr. N. Harbeck – PD Dr. A. Rody
Abstracts (HTML) List of Authors
A1
Bürger, H.: Basal, luminal and myoepithelial cells: immunophenotypical and molecular characterization
A2
Brauch, H.; Schroth, W.; Bacchus, L.; Simon, W.; Eichelbaum, M.; Schwab, M.: Endocrine Therapy: Translational Research on CYP2D6 Genetics for Tamoxifen Response in Breast Cancer
A3
Dittmer, J.: Communication between epithelial and stromal cells
A4
Gluz, O.: Resistance to chemotherapy
A5
Harbeck, N.: Molecular basis and possibilities for modulation of resistance to anti-HER2 therapy
A6
Holst, F.: ESR1 amplification in breast cancer – A new predictive marker?
A7
Jacobs, V. R.: Cost planning for oncological therapies from the clinic's point of view regarding clinical care and studies [Kostenplanung onkologischer Therapien aus Sicht der Klinik im Rahmen klinischer Versorgung und Studien]
A8
Yu-Poth, S.: Clinical and Molecular Parameters to Predict Therapy Response
A9
Liedtke, C.: Triple negative breast cancer – molecular basics and clinical impact
A10
Müller, V.; Fehm, T.; Janni, W.; Pantel, K.: Impact of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients
A11
Ortmann, O.; Brockhoff, G.; Treeck, O.; Buchholz, S.: Novel aspects in endocrine treatment of breast cancer
A12
Poremba, C.: Molecular and phenotypic changes in the mammary gland in different phases of life: Puberty, pregnancy and menopause
A13
Raab, M.; Mattheß, Y.; Kaufmann, M.; Strebhardt, K.: Breast Cancer, inflammation and proliferation
A14
Reimer, T.: Antiangiogenic therapy: the problem of redundant pathways
A15
Rody, A.: The Cancer Stem-Cell Hypothesis of Breast Cancer
A16
Rüschoff, J.: The Role of Her-2 in the Carcinogenesis of Breast Cancer – When and Where?
A17
Schneeweiss, A.: Molecular techniques for identification of new prognostic and predictive markers
A18
Spänkuch, B.: „Gene therapy“: from bench to bedside?
A19
Stickeler, E.: Pathophysiology of EGFR and options of targeting
A20
Minckwitz, G. von: Clinical testing of new molecular agents – do we have a clinical trial problem?
A21
Wülfing, P.: Angiogenesis/tumor hypoxia: new treatment options?